Regulatory reporting is crucial for multiple reasons. Firstly, it ensures the safety and efficacy of new cancer treatments. Secondly, it provides a systematic way to monitor and address adverse events that may arise during clinical trials or post-market surveillance. Lastly, it fosters transparency and trust among patients, healthcare providers, and researchers.
